$32.00

i 1.75 Hours

Course Overview

Drug-induced kidney and liver injury is a major problem throughout the world. Some of the most commonly prescribed drugs are involved in the pathogenesis of kidney and liver toxicity, including antibiotics, acetaminophen (Tylenol®), non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., ibuprofen [Advil®]), and angiotensin-converting enzyme (ACE) inhibitors. These frequently prescribed medications can result in kidney and liver toxicities, and many are available over the counter. Therefore, it is imperative that healthcare providers are aware of which agents commonly cause kidney or liver injury, symptoms that may indicate toxicity, abnormalities in lab values that indicate kidney or liver injury, and potential preventive measures.

The goal of this course is to provide healthcare professionals with in-depth understanding of common drugs and other agents that are nephrotoxic or hepatotoxic.

About the Course Author

Dr. Gibson is a pharmacist and medical communicator. She trained as a hospital pharmacist specializing in internal medicine and acute care. In this role, she helped implement patient safety initiatives and investigate medication errors and adverse drug reactions in hospital settings. She evaluates and consults on clinical performance and risk reduction in the healthcare industry and in other high-reliability organizations. Dr. Jennifer Gibson PharmD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Sooa Devereaux, MSN, RN-BC is a SME writer with Relias. She has over 25 years of nursing experience, primarily in acute care and professional development. Sooa Devereaux, MSN, RN-BC has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.

Get started now and your first course is free!


Become a member today and enjoy instant savings on all courses

Accreditation Information

Certificates provided by accrediting body (17 Match)

  • American Nurses Credentialing Center

    1.75HOURS


    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Nurses will receive 1.75 Nursing Contact Hours after successfully completing this course.
  • California Board of Registered Nursing

    1.75HOURS

    Provider approved by the California Board of Registered Nursing, CEP# 13791 Nurses will receive 1.75 contact hours for participating in this course.
  • District of Columbia Board of Nursing

    1.70HOURS


    District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).

    Nurses will receive 1.7 contact hours for participating in this course.
  • Florida Board of Nursing

    1.50HOURS

    Florida Board of Nursing (CEBroker Provider #50-290). Nurses will receive 1.5 contact hours for participating in this course.
  • Georgia Board of Nursing

    1.75HOURS

    Georgia Board of Nursing (CEBroker Provider #50-290). Nurses will receive 1.75 contact hours for participating in this course.
  • Accreditation Council for Continuing Medical Education

    1.75HOURS


    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Relias LLC designates this enduring activity for a maximum of 1.75 AMA PRA category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • South Carolina Board of Nursing

    1.75HOURS

    This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CEBroker Provider #50-290).
    Nurses will receive 1.75 contact hours for participating in this course.
  • Florida Board of Medicine

    1.75HOURS

    Florida Board of Medicine (CEBroker Provider #50-290).
  • Florida Physician Assistants

    1.75HOURS

    Florida Physician Assistants (CEBroker Provider #50-290)
  • West Virginia Board of Registered Nursing

    1.75HOURS

    West Virginia Board of Registered Nursing (CEBroker Provider #50-290).
    Nurses will receive 1.75 contact hours for participating in this course.
  • Accreditation Council for Pharmacy Education

    1.75HOURS


    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Type Activity: Knowledge
    Target Audience Designation: P
    ACPE Universal Activity Number: JA4008266-0000-21-043-H01-P
  • New Mexico Board of Nursing

    1.75HOURS

    New Mexico Board of Nursing (CEBroker Provider #50-290).
    Nurses will receive 1.75 contact hours for participating in this course.
  • Arkansas State Board of Nursing

    1.75HOURS

    Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
    Nurses will receive 1.75 contact hours for participating in this course.
  • Ohio State Medical Board

    1.75HOURS

    State Medical Board of Ohio (CEBroker Provider #: 50-290)
  • Louisiana State Board of Medical Examiners

    1.75HOURS

    Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
  • Mississippi State Board of Medical Licensure

    1.75HOURS

    Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
  • Florida Board of Pharmacy

    1.75HOURS

    This module is approved for 1.75 contact hours by Florida Board of Pharmacy


Course Details
  • Course Code:

    REL-ACU-0-DKLI
  • Hours:

    1.75
  • Type:

    Online Course
  • Release Date:

    2021-08-01
  • Expiration Date:

    2024-06-30
  • Learning Objectives:

    Examine the roles of healthcare professionals in the prevention and management of kidney and liver toxicity.; Express the pathogenesis for drug­induced kidney and liver injury.; Identify drugs and supplements that commonly cause kidney and liver toxicity.
  • Outline:

    Section 1: Introduction
    About This Course  
    Learning Objectives
    Section 2: Kidney and Liver Toxicity in Healthcare
    Kidney and Liver Toxicity
    Case Study
    Roles of Each Healthcare Professional
    Section 3: Drug-Induced Kidney Injury
    Acute Kidney Injury
    Overview of Renal Physiology
    Definition of Acute Kidney Injury
    Pathophysiology of Acute Kidney Injury
    Detecting Acute Kidney Injury
    Risk Factors for Drug­Induced Acute Kidney Injury
    Preventive Measures
    Drugs Causing Kidney Toxicity
    Important Equations
    Section 4: Drug-Induced Liver Injury
    Liver Injury
    Risk Factors
    Diagnosis
    Monitoring and Treatment for DILI
    Section 5: Drugs Causing Liver Toxicity
    Intrinsic Drug Reactions
    Idiosyncratic Drug Reactions
    Review of Patient Case Study
    Section 6: Clinical Vignette
    Analyzing Nicole’s Case
    Section 7: Conclusion
    Course Summary
    Course Contributors
    Resources
    References
  • Target Audience:

    The target audience for this course is: Nurses; Physicians; in the following settings: Acute Care Facility.
  • Course Delivery Method and Format:

    Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
    Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
    If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
    All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
    Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
    All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
    To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
  • Accommodations:

    If you require special accommodations to complete this module, please contact Relias Customer Support here.
  • Disclosures:

    Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.